• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Tech

Here’s why this Canadian startup wants a piece of the crowded sunscreen market

By
Corinne Iozzio
Corinne Iozzio
Down Arrow Button Icon
By
Corinne Iozzio
Corinne Iozzio
Down Arrow Button Icon
July 30, 2015, 12:12 PM ET
Suncayr Sun Marker
Courtesy Suncayr

We all know we should wear sunscreen to protect ourselves from burns and help prevent skin cancer. Trouble is, putting on that protective layer of lotion, and keeping it up isn’t an exact science. Package instructions, and even the FDA, suggest reapplying sunscreen at least every two hours. Yet, many of us don’t reapply as often as we should—that is if we bother putting on any protection at all.

Canadian startup Suncayr is currently testing, what it believes is, a foolproof way to monitor UV exposure and tell users the minute they need to slather on more sunblock. Their solution, called the Sun Marker, changes from clear to purple in UV light.

The marker, which looks like a standard Crayola felt-tip pen, contains a UV-sensitive, non-toxic ink. Users apply a dot (or even a smiley face or line) to their skin and then put on their sunscreen. When the protection wears off, the ink reacts with the sun’s UV rays and turns purple. Once the ink is re-covered with sunblock, it turns clear.

 

Suncayr began two years ago as the final project for a group of nano-engineering students at the University of Waterloo in Ontario, Canada. The team, which is now led by CEO and co-founder Rachel Pautler, wanted to focus on solving a problem people face on a day-to-day basis. “I get sunburned super easily,” she says, “and two of my co-founders have skin-cancer history in their families, so they’re more worried about the effects of the sun.”

After some debate about the ideal form factor—the team considered a wearable device, a patch, and a smartphone app—they settled on a color-changing skin-worn ink. “We finalized on this idea, because it’s so simple and easy to do that a kid could do it.”

According to Pautler, reaching out to kids will be Suncayr’s most-important task. One highly-cited study out of Brown University’s Warren Alpert Medical School found that kids who suffer five or more severe burns before the age of 20 are up to 80% more likely to develop melanoma as adults.

What’s more, because Suncayr ink will be applied directly to skin it should provide a more-accurate measure of UV exposure than other methods. “We knew we needed something that was applied directly to the skin, so it could be specific to your skin,” she explains, “Myself and my co-founders, for example, burn at different rates, and we sweat at different rates. This is a one-size-fits-all solution.”

Competing products, such at the Netatmo June wristband and the Goodlux Sunsprite lapel clasp, can keep a tally of how much sunlight a user is exposed to, but aren’t precise enough to know when it’s time to reapply and don’t adjust based on conditions like sweat and moisture.

[fortune-brightcove videoid=4023452664001]

 

Those shortcomings are why Pautler thinks there’s more than enough room in the more than $1.3 billion sunscreen market for the Sun Marker. When Suncayr launches the product next summer (it’ll run about $15 for one marker) it will be a standalone product. Eventually, she could see it licensed to or packaged with existing sunscreen brands.

Right now, the team is still testing the Sun Marker ink for toxicity before they begin any human testing. From there, they’ll wait for clearance from Health Canada, their FDA equivalent, before pushing Sun Marker online or onto store shelves.

The company is currently working off of about $116,000 in grants and awards, including one from the University of Waterloo and a stay in local bootcamp Communitech—they were also named a runner-up in the 2014 James Dyson Awards. Next, according to Pautler, the company will need to raise about another half-million to get the product to market.

 

About the Author
By Corinne Iozzio
See full bioRight Arrow Button Icon

Latest in Tech

Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025

Most Popular

Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Leadership
  • Success
  • Tech
  • Asia
  • Europe
  • Environment
  • Fortune Crypto
  • Health
  • Retail
  • Lifestyle
  • Politics
  • Newsletters
  • Magazine
  • Features
  • Commentary
  • Mpw
  • CEO Initiative
  • Conferences
  • Personal Finance
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.


Most Popular

placeholder alt text
Economy
Right before Trump named Warsh to lead the Fed, Powell seemed to respond to some of his biggest complaints about the central bank
By Jason MaJanuary 30, 2026
21 hours ago
placeholder alt text
Politics
The American taxpayer spent nearly half a billion dollars deploying federal troops to U.S. cities in 2025, CBO finds
By Nick LichtenbergJanuary 28, 2026
3 days ago
placeholder alt text
Economy
'I just don't have a good feeling about this': Top economist Claudia Sahm says the economy quietly shifted and everyone's now looking at the wrong alarm
By Eleanor PringleJanuary 31, 2026
7 hours ago
placeholder alt text
North America
'I meant what I said in Davos': Carney says he really is planning a Canada split with the U.S. along with 12 new trade deals
By Rob Gillies and The Associated PressJanuary 28, 2026
3 days ago
placeholder alt text
AI
Top engineers at Anthropic, OpenAI say AI now writes 100% of their code—with big implications for the future of software development jobs
By Beatrice NolanJanuary 29, 2026
2 days ago
placeholder alt text
Big Tech
Microsoft’s $440 billion wipeout, and investors angry about OpenAI’s debt, explained
By Eva RoytburgJanuary 29, 2026
2 days ago

Latest in Tech

Netflix
Big TechMarkets
Netflix may be turning into an ‘entertainment giant,’ but its stock looks like ‘dead money’ to investors
By Nick LichtenbergJanuary 31, 2026
1 hour ago
In this handout, the mug shot of Jeffrey Epstein, 2019.
PoliticsJeffrey Epstein
Elon Musk and Jeffrey Epstein emailed each other for years trying to meet up, new Justice Department records show
By Eva Roytburg and Sasha RogelbergJanuary 30, 2026
14 hours ago
Big TechThe Boring Company
After a decade of silence, Elon Musk’s tunneling startup and its reclusive president, are hitting the media circuit
By Jessica MathewsJanuary 30, 2026
17 hours ago
MagazineEducation
The 1966 cover of Fortune Magazine welcomed the Information age. Now the AI era beckons
By Indrani SenJanuary 30, 2026
18 hours ago
Gamestop
Big TechGameStop
Five years after the short squeeze, GameStop’s CEO is betting on a ‘genius or totally foolish’ $100 billion-plus acquisition
By Jake AngeloJanuary 30, 2026
19 hours ago
C-SuitePharmaceutical Industry
‘We’ll save the world from cancer’: Inside Pfizer CEO’s $23 billion post‑COVID bet on oncology
By Nick LichtenbergJanuary 30, 2026
20 hours ago